Enrolling By Invitation PHASE4 INTERVENTIONAL 2-arm NCT05970354

EMLA Cream as Analgesic for Outpatient Gynecological Procedures

Lidocaine-Prilocaine Cream as Analgesic for Outpatient Gynecological Procedures; A Randomized-Control Trial

Sponsor: CAMC Health System

Conditions Pain

Interventions EMLA Cream VersaPro Cream Base for Compounding

Updated 6 times since 2023 Last updated: Jul 31, 2024 Started: Sep 15, 2023 Primary completion: Dec 31, 2024 Completion: Feb 28, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Pain and is currently ongoing. CAMC Health System leads this study, which shows 6 recorded versions since 2023 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Enrolling By Invitation PHASE4
Aug 2024 — Sep 2024 [monthly]

Enrolling By Invitation PHASE4
Jul 2024 — Aug 2024 [monthly]

Enrolling By Invitation PHASE4
Dec 2023 — Jul 2024 [monthly]

Enrolling By Invitation PHASE4

Status: Not Yet Recruiting → Enrolling By Invitation
Oct 2023 — Dec 2023 [monthly]

Not Yet Recruiting PHASE4

▶ Show 1 earlier version

Sep 2023 — Oct 2023 [monthly]

Not Yet Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

CAMC Health System

Data source: CAMC Health System

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Charleston, United States